SVA
Sinovac Biotech Ltd
NASDAQ: SVA · HEALTHCARE · BIOTECHNOLOGY
$6.47
+0.00% today
Updated 2026-04-29
Market cap
$642.44M
P/E ratio
6.66
P/S ratio
1.83x
EPS (TTM)
$0.97
Dividend yield
850.00%
52W range
$6 – $6
Volume
—
Sinovac Biotech Ltd (SVA) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $22.42M | $23.37M | $37.01M | $57.45M | $77.44M | $145.48M | $214.36M | $215.91M | $208.76M | $240.69M | $238.53M | $202.93M | $211.35M | $211.35M | $369.78M | $452.30M | $1.90B | $16.75B | $14.11B | $13.66B |
| Cash & equivalents | $2.61M | $2.61M | $9.25M | $17.07M | $20.55M | $74.95M | $101.59M | $104.29M | $91.24M | $107.24M | $91.29M | $63.83M | $62.43M | $62.43M | $158.17M | $152.72M | $1.04B | $11.61B | $4.28B | $1.27B |
| Current assets | $8.47M | $8.47M | $21.74M | $39.18M | $55.57M | $119.31M | $147.29M | $132.04M | $126.28M | $157.25M | $154.80M | $128.49M | $134.24M | $130.75M | $284.18M | $349.61M | $1.56B | $14.92B | $12.13B | $11.83B |
| Total liabilities | $6.86M | $6.86M | $15.70M | $24.55M | $23.80M | $61.01M | $66.60M | $70.61M | $79.33M | $97.05M | $96.80M | $66.42M | $81.69M | $81.69M | $77.85M | $100.10M | $781.20M | $2.87B | $1.40B | $1.64B |
| Current liabilities | $6.66M | $6.66M | $11.86M | $20.44M | $17.24M | $51.01M | $45.76M | $39.53M | $30.16M | $49.16M | $79.83M | $58.14M | $66.26M | $66.26M | $58.20M | $87.20M | $679.61M | $2.41B | $1.09B | $1.15B |
| Long-term debt | $202000.00 | $2.66M | $3.84M | $1.37M | $2.19M | — | $10.06M | $17.32M | $34.41M | $32.15M | $1.80M | $756000.00 | $9.45M | $14.85M | $3.89M | $1.44M | $8.29M | $17.38M | $11.51M | $177.82M |
| Shareholder equity | $12.44M | $12.93M | $19.24M | $30.00M | $47.85M | $70.66M | $126.44M | $129.92M | $117.72M | $128.68M | $126.56M | $121.65M | $115.77M | $115.77M | $253.43M | $294.02M | $746.47M | $9.33B | $8.92B | $8.71B |
| Retained earnings | $-6.16M | $-5.66M | $-12.93M | $-7.11M | $-1.48M | $13.99M | $3.88M | $2.70M | $-12.16M | $-4.71M | $-6.38M | $-9.98M | $-11.91M | $-11.91M | $23.82M | $56.73M | $144.24M | $7.14B | $7.23B | $7.12B |
| Accounts receivable | $4.55M | $3.35M | $9.73M | $16.98M | $24.96M | $25.54M | $25.77M | $17.83M | $23.44M | $31.93M | $40.72M | $39.02M | $49.83M | $49.83M | $77.46M | $113.74M | $253.49M | $952.40M | $609.49M | $450.72M |
| Inventory | $487243.00 | $487243.00 | $2.08M | $3.75M | $8.01M | $9.60M | $14.86M | $8.11M | $10.53M | $14.33M | $18.71M | $18.66M | $14.10M | $14.10M | $25.09M | $27.85M | $105.81M | $375.51M | $180.72M | $139.87M |
| Goodwill | — | — | — | — | — | — | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — |